ASX - By Stock
|
DLM |
Re:
Ann: Board statement re Ramcap Ltd
|
|
Oupa
|
56 |
13K |
1 |
04/04/20 |
04/04/20 |
ASX - By Stock
|
56
|
13K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Board statement re Ramcap Ltd
|
|
Oupa
|
56 |
13K |
1 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
56
|
13K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
I'm back
|
|
Oupa
|
3 |
898 |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
3
|
898
|
1
|
|
ASX - By Stock
|
DLM |
Re:
What's going on
|
|
Oupa
|
45 |
10K |
0 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
45
|
10K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
What's going on
|
|
Oupa
|
45 |
10K |
3 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
45
|
10K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Appendix 4E and 2019 full year accounts
|
|
Oupa
|
95 |
481K |
3 |
14/03/20 |
14/03/20 |
ASX - By Stock
|
95
|
481K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Stimulus Package
|
|
Oupa
|
11 |
4.7K |
0 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
11
|
4.7K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Completion of recruitment to paxalisib P2 GBM study
|
|
Oupa
|
25 |
7.3K |
4 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
25
|
7.3K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Completion of recruitment to paxalisib P2 GBM study
|
|
Oupa
|
25 |
7.3K |
2 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
25
|
7.3K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
What's going on
|
|
Oupa
|
45 |
10K |
5 |
08/03/20 |
08/03/20 |
ASX - By Stock
|
45
|
10K
|
5
|
|
ASX - By Stock
|
DLM |
Re:
What's going on
|
|
Oupa
|
45 |
10K |
2 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
45
|
10K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
Oupa
|
45 |
11K |
6 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
45
|
11K
|
6
|
|
ASX - By Stock
|
DLM |
Re:
What's going on
|
|
Oupa
|
45 |
10K |
0 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
45
|
10K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Compelling results for 2591 dose ranging study in PMS model
|
|
Oupa
|
44 |
22K |
0 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
44
|
22K
|
0
|
|
ASX - By Stock
|
DLM |
Re:
What's going on
|
|
Oupa
|
45 |
10K |
0 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
45
|
10K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
2020 A brand new year for Kazia
|
|
Oupa
|
113 |
39K |
10 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
113
|
39K
|
10
|
|
ASX - By Stock
|
DLM |
Re:
What's going on
|
|
Oupa
|
45 |
10K |
0 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
45
|
10K
|
0
|
|
ASX - By Stock
|
DLM |
What's going on
|
|
Oupa
|
45 |
10K |
0 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
45
|
10K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
2020 A brand new year for Kazia
|
|
Oupa
|
113 |
39K |
4 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
113
|
39K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
2020 A brand new year for Kazia
|
|
Oupa
|
113 |
39K |
9 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
113
|
39K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Market
|
|
Oupa
|
79 |
945K |
3 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
79
|
945K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Appendix 4E and 2019 full year accounts
|
|
Oupa
|
95 |
481K |
2 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
95
|
481K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Appendix 4E and 2019 full year accounts
|
|
Oupa
|
95 |
481K |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
95
|
481K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 5 Orphan Drug programs and Rett in Phase 3 funded by partner
|
|
Oupa
|
49 |
1.6M |
6 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
49
|
1.6M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 5 Orphan Drug programs and Rett in Phase 3 funded by partner
|
|
Oupa
|
49 |
1.6M |
1 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
49
|
1.6M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
Oupa
|
467 |
2.3M |
2 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
467
|
2.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
Oupa
|
467 |
2.3M |
2 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
467
|
2.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
Oupa
|
467 |
2.3M |
6 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
467
|
2.3M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Update on trofinetide Phase 3 trial in Rett syndrome
|
|
Oupa
|
13 |
11K |
3 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
13
|
11K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Update on trofinetide Phase 3 trial in Rett syndrome
|
|
Oupa
|
13 |
11K |
3 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
13
|
11K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Update on trofinetide Phase 3 trial in Rett syndrome
|
|
Oupa
|
13 |
11K |
0 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
13
|
11K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
How long?.
|
|
Oupa
|
143 |
112K |
2 |
16/02/20 |
16/02/20 |
ASX - By Stock
|
143
|
112K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
How long?.
|
|
Oupa
|
143 |
112K |
1 |
16/02/20 |
16/02/20 |
ASX - By Stock
|
143
|
112K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
How long?.
|
|
Oupa
|
143 |
112K |
2 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
143
|
112K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
How long?.
|
|
Oupa
|
143 |
112K |
1 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
143
|
112K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
How long?.
|
|
Oupa
|
143 |
112K |
1 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
143
|
112K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
How long?.
|
|
Oupa
|
143 |
112K |
0 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
143
|
112K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: $8.1M Financing & Re-Set of Capital Structure
|
|
Oupa
|
15 |
6.7K |
4 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
15
|
6.7K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Interesting
|
|
Oupa
|
112 |
48K |
1 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
112
|
48K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Interesting
|
|
Oupa
|
112 |
48K |
1 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
112
|
48K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Interesting
|
|
Oupa
|
112 |
48K |
1 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
112
|
48K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Interesting
|
|
Oupa
|
112 |
48K |
3 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
112
|
48K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
Oupa
|
467 |
2.3M |
8 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
467
|
2.3M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
Oupa
|
467 |
2.3M |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
467
|
2.3M
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Funding
|
|
Oupa
|
121 |
56K |
8 |
02/02/20 |
02/02/20 |
ASX - By Stock
|
121
|
56K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
2020 A brand new year for Kazia
|
|
Oupa
|
113 |
39K |
6 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
113
|
39K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Trading
|
|
Oupa
|
467 |
2.3M |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
467
|
2.3M
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Non-Deal Roadshow Presentation
|
|
Oupa
|
4 |
2.7K |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
4
|
2.7K
|
1
|
|
ASX - By Stock
|
SIL |
Re:
Ann: Withdrawal of Material Legal Matter
|
|
Oupa
|
2 |
3.3K |
0 |
23/01/20 |
23/01/20 |
ASX - By Stock
|
2
|
3.3K
|
0
|
|
ASX - By Stock
|
SIL |
Re:
Ann: Withdrawal of Material Legal Matter
|
|
Oupa
|
2 |
3.3K |
0 |
16/01/20 |
16/01/20 |
ASX - By Stock
|
2
|
3.3K
|
0
|
|